Decreased secretion of IL-6, TNF-α, and MCP-1; decreased expression of MHC II, MARCO, CD80, CD86; survival benefit in LPS-induced endotoxemia. The gene discussed is MARCO; the disease is serum lipopolysaccharide activity.